Researchers noticed responses in almost 42% of sufferers with synovial sarcoma or myxoid/spherical cell liposarcoma handled with lete-cel in a section 2 trial.A...
Sufferers with PSMA-positive metastatic castration-resistant prostate most cancers in a part 3 trial confirmed optimistic outcomes after receiving 177Lu-PSMA-I&T.Remedy with 177Lu-PSMA-I&T in sufferers...